Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending March 2009. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, specifically regarding changes in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific share transaction notification and does not contain financial statements or performance metrics.
Material Changes
The filing details a specific transaction on March 18, 2009, where Mr. S M Bicknell purchased 691 Ordinary shares of GlaxoSmithKline plc within an ISA at a price of £10.28 per share. No other material changes to the company's operations or financial position are reported in this document.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is strictly a regulatory disclosure of a director's share purchase.
Key Facts for Investor Verification
- Transaction Date: March 18, 2009
- Person Involved: Mr. S M Bicknell
- Transaction Type: Purchase of Ordinary shares
- Quantity: 691 shares
- Price per Share: £10.28
- Regulatory Basis: Disclosure and Transparency Rule 3.1.4R(1)(a)